Covered recipient · General Payments record
JANICE MAY STEPHENSON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$933.31
- Reported across 46 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $378.81 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $107.30 | 2 |
| Novo Nordisk AS | $68.36 | 4 |
| Lilly USA, LLC | $51.97 | 3 |
| Amgen Inc. | $47.53 | 3 |
| Exact Sciences Corporation | $42.24 | 2 |
| Inspire Medical Systems, Inc. | $21.19 | 1 |
| Abbott Laboratories | $20.16 | 1 |
| Esperion Therapeutics, Inc. | $20.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.16 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240883963 | CMS |
| Amgen Inc. | $16.04 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228357326 | CMS |
| Amgen Inc. | $16.04 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228357330 | CMS |
| Amgen Inc. | $15.45 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228357321 | CMS |
| Boston Scientific Corporation | $54.20 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181213568 | CMS |
| Boston Scientific Corporation | $53.10 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181213566 | CMS |
| Esperion Therapeutics, Inc. | $20.06 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243976609 | CMS |
| Exact Sciences Corporation | $20.53 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235496055 | CMS |
| Exact Sciences Corporation | $21.71 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235496060 | CMS |
| Inspire Medical Systems, Inc. | $21.19 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251511638 | CMS |
| Lilly USA, LLC | $18.50 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186736475 | CMS |
| Lilly USA, LLC | $14.20 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186685219 | CMS |
| Lilly USA, LLC | $19.27 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186674937 | CMS |
| Novo Nordisk Inc | $15.03 | 06/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188664886 | CMS |
| Novo Nordisk Inc | $17.33 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188372474 | CMS |
| Novo Nordisk Inc | $17.95 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188999789 | CMS |
| Novo Nordisk Inc | $18.05 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188307139 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.